Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Category - Medical Devices & Diagnostics
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
Trinity Biotech Reports Breakthrough Clinical Trial Results for...
Trinity Biotech has announced positive clinical trial results for its newly redesigned continuous...
Bayer Presents VICTOR Phase III Results for Vericiguat in Heart...
Bayer has shared new data from the VICTOR Phase III vericiguat heart failure trial in patients with...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...
Caris Validates MI Cancer Seek® as Reliable Companion Diagnostic...
Caris Life Sciences® (NASDAQ: CAI) has published peer-reviewed clinical validation data in...
FluoGuide Accelerates FG001 Commercialization Through Industry...
Copenhagen, Denmark—10 August 2025 – FluoGuide A/S has released highlights from its live-recorded...

